Nuvation Bio Inc.
NYSE:NUVB
2.3 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1.435 | 0 | 0.264 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 1.591 | 0.058 | 0.055 | 0.055 | 0.038 | 0.039 | 0.106 | 0.217 | 0.114 | 0.047 | 0.043 | 0.07 | 0.041 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.156 | -0.058 | 0.209 | -0.055 | -0.038 | -0.039 | -0.106 | -0.217 | -0.114 | -0.047 | -0.043 | -0.07 | -0.041 | -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| -0.109 | 0 | 0.792 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 29.247 | 12.842 | 15.351 | 18.561 | 18.59 | 18.787 | 16.871 | 21.294 | 28.922 | 20.729 | 22.002 | 17.122 | 14.034 | 15.879 | 9.336 | 8.627 | 7.345 | 7.295 | 8.8 | 4.036 | 6.135 | 6.135 |
General & Administrative Expenses
| 15.656 | 7.357 | 5.48 | 7.778 | 7.541 | 7.734 | 7.464 | 8.044 | 8.948 | 7.463 | 7.607 | 5.669 | 6.4 | 4.605 | 4.432 | 2.919 | 1.672 | 1.925 | 1.631 | 1.229 | 1.867 | 1.867 |
Selling & Marketing Expenses
| 0.256 | -0.058 | -0.055 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.19 | 0.21 | 0 | 0 |
SG&A
| 15.912 | 7.299 | 5.425 | 7.778 | 7.541 | 7.734 | 7.464 | 8.044 | 8.948 | 7.463 | 7.607 | 5.669 | 6.4 | 4.605 | 4.432 | 2.919 | 1.672 | 1.925 | 1.821 | 1.439 | 1.867 | 1.867 |
Other Expenses
| -0.247 | -0.265 | -0.26 | -0.228 | -0.231 | -0.23 | -0.225 | -0.263 | -0.215 | -0.169 | -0.19 | -0.17 | -0.176 | -0.108 | -0.103 | -0.052 | -0.056 | -0.06 | 0 | 0 | 0 | 0 |
Operating Expenses
| 45.159 | 20.141 | 20.776 | 26.339 | 26.131 | 26.521 | 24.335 | 29.338 | 37.87 | 28.192 | 29.609 | 22.791 | 20.434 | 20.484 | 13.768 | 11.546 | 9.017 | 9.22 | 10.644 | 5.53 | 8.004 | 8.004 |
Operating Income
| -45.315 | -20.199 | -20.831 | -26.339 | -26.131 | -26.521 | -24.335 | -29.338 | -37.87 | -28.192 | -29.609 | -22.791 | -20.434 | -20.484 | -13.768 | -11.546 | -9.017 | -9.22 | -10.621 | -5.475 | -8.002 | -8.002 |
Operating Income Ratio
| -31.578 | 0 | -78.905 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -417.177 | 5.407 | 7.044 | 0.167 | -0.595 | 4.795 | 3.49 | 2.135 | 3.012 | 6.899 | 3.573 | -0.035 | 0.325 | -0.356 | 0.029 | 0.067 | -0.104 | -0.045 | 0.61 | 0.566 | -1.315 | -1.315 |
Income Before Tax
| -462.492 | -14.792 | -13.787 | -19.649 | -20.64 | -21.726 | -20.845 | -27.203 | -34.858 | -21.293 | -25.134 | -21.979 | -19.333 | -20.402 | -13.28 | -11.034 | -8.599 | -8.746 | -10.011 | -4.909 | -9.316 | -9.316 |
Income Before Tax Ratio
| -322.294 | 0 | -52.223 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | 0.015 | 17.435 | -6.918 | -5.722 | -4.795 | -13.4 | -2.135 | -3.012 | -6.899 | -4.475 | -1.794 | -2.378 | -0.272 | -0.488 | -1.076 | -0.892 | -1.008 | 0 | 0 | -1.315 | -1.315 |
Net Income
| -462.492 | -14.792 | -13.787 | -19.649 | -20.64 | -16.931 | -7.445 | -25.068 | -31.846 | -14.394 | -25.134 | -21.979 | -19.333 | -20.402 | -13.28 | -11.034 | -8.599 | -8.746 | -10.011 | -4.909 | -9.316 | -9.316 |
Net Income Ratio
| -322.294 | 0 | -52.223 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -1.89 | -0.068 | -0.063 | -0.09 | -0.094 | -0.077 | -0.034 | -0.11 | -0.15 | -0.067 | -0.12 | -0.11 | -0.095 | -0.12 | -0.061 | -0.051 | -0.04 | -0.04 | -0.042 | -0.022 | -0.051 | -0.051 |
EPS Diluted
| -1.89 | -0.068 | -0.063 | -0.09 | -0.094 | -0.077 | -0.034 | -0.11 | -0.15 | -0.067 | -0.11 | -0.11 | -0.095 | -0.12 | -0.061 | -0.051 | -0.04 | -0.04 | -0.042 | -0.022 | -0.051 | -0.051 |
EBITDA
| -45.071 | -20.141 | -20.776 | -26.679 | -25.711 | -26.511 | -24.527 | -29.553 | -40.208 | -34.256 | -33.329 | -22.856 | -20.894 | -20.206 | -13.873 | -11.639 | -8.943 | -9.211 | -10.613 | -5.473 | -1.315 | -1.315 |
EBITDA Ratio
| -31.408 | 0 | -78.697 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |